5 Topic Commentaries
Procedural Pharmaceutical Lessons From Early Adopters
-
Janet Woodcock, MD
Drug regulation and pharmaceutical quality
•U.S. Food and Drug Administration
SourceThen, you bring in the early adopters, you talk to them about what the change should be, and try to figure it out.
-
Larisa Cavallari, PharmD
Pharmacogenomics and precision medicine
•University of Florida College of Pharmacy
SourceOur genotype-guided approached led to a reduction in patient-reported pain over three months in the people who we expected to benefit the most. These findings add to the evidence base that pharmacogenetics testing improves outcomes and justifies broader implementation across health care.
-
R. David Anderson, MD
Interventional cardiology
•University of Florida College of Medicine
SourceThis helps us prescribe the right medication the first time and absolutely has the potential to reduce complications.
-
Siegfried Schmidt, MD, PhD, FAAFP
Family medicine and pain management
•University of Florida College of Medicine
SourcePharmacogenetic testing has provided us some answers why this is happening and helped us determine the right drugs, in the right dosages, at the right time for our patients. This is the future of medicine, and what I want to become reality for all of my patients.
-
Julie Johnson, PharmD
Clinical pharmacology and pharmacogenomics
•University of Florida College of Pharmacy
SourceWe’re excited to be one of the first places in the state to use genetic information to guide treatment decisions …
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







